Literature DB >> 32326783

The role of the triggering receptor expressed on myeloid cells-1 (TREM-1) in non-bacterial infections.

Amanda de Oliveira Matos1, Pedro Henrique Dos Santos Dantas1, Marcelle Figueira Marques Silva-Sales1, Helioswilton Sales-Campos1.   

Abstract

The triggering receptor expressed on myeloid cells 1 (TREM-1) is a receptor of the innate immune system, expressed mostly by myeloid cells and primarily associated with pro- inflammatory responses. Although the exact nature of its ligands has not yet been fully elucidated, many microorganisms or danger signals have been proposed as inducers of its activation or the secretion of sTREM-1, the soluble form with putative anti-inflammatory effects. In the course of the 20 years since its first description, several studies have investigated the involvement of TREM-1 in bacterial infections. However, the number of studies describing the role of TREM-1 in fungal, viral and parasite-associated infections has only increased in the last few years, showing a diverse contribution of the receptor in these scenarios, with beneficial or detrimental activities depending on the context. Therefore, this review aims to discuss how TREM-1 may influence viral, fungal and parasitic infection outcomes, highlighting its potential as a therapeutic target and biomarker for diagnosis and prognosis of non-bacterial infectious diseases.

Entities:  

Keywords:  Immune receptors; fungus; inflammation; parasite; virus

Year:  2020        PMID: 32326783     DOI: 10.1080/1040841X.2020.1751060

Source DB:  PubMed          Journal:  Crit Rev Microbiol        ISSN: 1040-841X            Impact factor:   7.624


  5 in total

Review 1.  Targeting Mononuclear Phagocyte Receptors in Cancer Immunotherapy: New Perspectives of the Triggering Receptor Expressed on Myeloid Cells (TREM-1).

Authors:  Federica Raggi; Maria Carla Bosco
Journal:  Cancers (Basel)       Date:  2020-05-23       Impact factor: 6.639

2.  sTREM-1 Predicts Disease Severity and Mortality in COVID-19 Patients: Involvement of Peripheral Blood Leukocytes and MMP-8 Activity.

Authors:  Pedro V da Silva-Neto; Jonatan C S de Carvalho; Vinícius E Pimentel; Malena M Pérez; Diana M Toro; Thais F C Fraga-Silva; Carlos A Fuzo; Camilla N S Oliveira; Lilian C Rodrigues; Jamille G M Argolo; Ingryd Carmona-Garcia; Nicola T Neto; Camila O S Souza; Talita M Fernandes; Victor A F Bastos; Augusto M Degiovani; Leticia F Constant; Fátima M Ostini; Marley R Feitosa; Rogerio S Parra; Fernando C Vilar; Gilberto G Gaspar; José J R da Rocha; Omar Feres; Fabiani G Frantz; Raquel F Gerlach; Sandra R Maruyama; Elisa M S Russo; Angelina L Viana; Ana P M Fernandes; Isabel K F M Santos; Vânia L D Bonato; Antonio L Boechat; Adriana Malheiro; Ruxana T Sadikot; Marcelo Dias-Baruffi; Cristina R B Cardoso; Lúcia H Faccioli; Carlos A Sorgi
Journal:  Viruses       Date:  2021-12-15       Impact factor: 5.048

3.  Clinical Value of sTREM-1, PCT, and 1,3-β-D Glucan in Diagnosis of Immune-Associated Pulmonary Interstitial Disease with Fungal Infection.

Authors:  Lei Yan; Yuan Li; Chunye Wu; Yuquan Shi; Chunyu Kong
Journal:  Biomed Res Int       Date:  2022-07-27       Impact factor: 3.246

4.  Diagnostic and prognostic predictive values of triggering receptor expressed on myeloid cell-1 expression in neonatal sepsis: A meta-analysis and systematic review.

Authors:  Chenyang Chang; Qiannan Gao; Guoping Deng; Kaiyuan Luo; Huifang Zhu
Journal:  Front Pediatr       Date:  2022-07-22       Impact factor: 3.569

5.  Potential role of Triggering Receptor Expressed on Myeloid Cells-1 (TREM-1) in SARS-CoV-2 infection: First insights.

Authors:  Ayane de Sá Resende; Yrna Lorena Matos de Oliveira; Tatiana Rodrigues de Moura; Paulo Ricardo Martins-Filho
Journal:  EXCLI J       Date:  2021-03-26       Impact factor: 4.068

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.